Blue Ridge Bankshares, the Richmond, Virginia-based holding company for Blue Ridge Bank, has spent the past two years rebuilding after exiting higher-risk fintech lending and working through a regulatory consent order. That order was lifted in late 2025, shifting management's focus to soundness, profitability, and growth in its core community banking markets. This quarter's report is significant because it tests whether that turnaround can hold up against credit headwinds. Investors are also watching closely because the company's pending merger with HomeTrust Bancshares means current results set the baseline for the combined institution's trajectory. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the quarter ended September 30, 2026, Blue Ridge Bankshares reported a net loss of $4.2 million, or ($0.05) per diluted common share. That compares with a net loss of $1.3 million, or ($0.01) per diluted share, in the second quarter of 2026, and net income of $5.6 million, or $0.06 per diluted share, in the third quarter of 2025.
The loss was driven primarily by an $8.0 million provision for credit losses on loans, up from $3.5 million in the prior quarter. Management attributed the charge to a single out-of-market relationship originated before 2024 by the company's former government-guaranteed lending team. Net loan charge-offs totaled $10.3 million, of which $9.9 million came from that borrower, which operates in hydroponic farming.
Operationally, results improved. Net interest income rose to $17.4 million from $16.5 million in the prior quarter, while net interest margin expanded to 3.08% from 2.91%. Cost of deposits declined to 2.22%, and noninterest expense held steady at $15.9 million. Noninterest income increased to $2.6 million. Adjusted pre-tax earnings reached $5.3 million, an improvement of about 85% from the prior quarter's $2.9 million. From what I see, the margin expansion points to better underlying lending economics even as one-time items dominate the bottom line.
Investor focus after the report centered on the contrast between improving core profitability and the one-time credit charge. The expanded net interest margin, lower deposit costs, and disciplined expense control signal progress on the company's operational turnaround. However, the outsized charge-off on the legacy out-of-market loan underscores the lingering asset-quality risk in a portfolio still being de-risked. Sentiment is also shaped by the HomeTrust merger, which reframes the stock less around standalone earnings momentum and more around the value and timing of the pending combination.
The most important item on the calendar is the proposed merger with HomeTrust Bancshares. Announced in August 2026, the transaction would combine Blue Ridge Bankshares and Blue Ridge Bank into HomeTrust, and it is expected to close in the first quarter of 2027, subject to shareholder and regulatory approvals. Until then, merger-related expenses will likely continue to appear in quarterly results.
On asset quality, management described the credit problems affecting the hydroponic farming borrower as unique and not systemic to the broader loan book. After the third-quarter charge-off, roughly $1.5 million of exposure to that borrower remained. Investors should watch whether nonperforming assets, which fell to $26.7 million, or 1.14% of total assets, continue to decline.
Balance-sheet trends also matter. Loans held for investment grew $33.1 million sequentially, partly through a third-party residential mortgage program, while the company fully redeemed its subordinated notes and increased borrowing from the Federal Home Loan Bank (FHLB) by $86.0 million. Sustaining loan growth without adding meaningful credit risk will be a key test of the community-bank strategy heading into 2027. I'm watching this closely as the merger timeline approaches.
One thing that stands out when analyzing earnings like these is how AI-driven platforms can help surface comparable situations across the sector. I’ve found Tickeron’s AI Screener particularly useful for quickly filtering banks by metrics such as net interest margin trends, asset quality ratios, and recent performance. It allows me to cross-check ideas against thousands of securities without spending hours on manual screens, which keeps my focus on the data that actually moves the needle for names like BRBS.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for BRBS turned positive on October 15, 2026. Looking at past instances where BRBS's MACD turned positive, the stock continued to rise in 28 of 41 cases over the following month. The odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on BRBS as a result. In 59 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
BRBS moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BRBS crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +2.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRBS advanced for three days, in 137 of 217 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 80 of 151 cases where BRBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRBS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
BRBS broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.296) is normal, around the industry mean (1.269). P/E Ratio (39.800) is within average values for comparable stocks, (13.240). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (1.190). BRBS's Dividend Yield (0.603) is considerably higher than the industry average of (0.035). P/S Ratio (4.399) is also within normal values, averaging (3.738).
The Tickeron Seasonality Score of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. BRBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRBS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company for Blue Ridge Bank, which engages in the provision of commercial banking and mortgage lending services.
Industry RegionalBanks